International Stem Cell Corporation Announces Operating Results for the Three and Six-Months ended June 30, 2017
August 14, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...
International Stem Cell Corporation Announces Operating Results for the Quarter ended March 31, 2017
May 17, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...
International Stem Cell Corporation Receives Approval to Start Second Patient Cohort in Clinical Trial for Parkinson’s Disease
May 09, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation to Present Results of Neural Stem Cell Transplantation for Parkinson's Disease at the ASGCT 2017 Annual Meeting
May 04, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial
April 25, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 25, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...
International Stem Cell Corporation Announces 2016 Fourth Quarter and Year-End Results
April 05, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Announces Third Patient with Parkinson's Disease in Phase I Clinical Trial
February 28, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Feb. 28, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
Lifeline Skin Care a Subsidiary of ISCO Announces New Products and Marketing Campaigns
December 20, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Dec. 20, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Announces Second Patient with Parkinson’s Disease Treated in Phase I Clinical Trial
December 07, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Dec. 07, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Announces Operating Results for the Three and Nine-months ended September 30, 2016
November 16, 2016 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology...